Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000814133-24-000038
Filing Date
2024-02-09
Accepted
2024-02-09 13:56:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 nrix224.txt SC 13G/A 2467
  Complete submission text file 0000814133-24-000038.txt   4233
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS LP (Filed by) CIK: 0000814133 (see all company filings)

EIN.: 870319391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Subject) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-91591 | Film No.: 24613869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)